Squarepoint Ops LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 206 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$204,274
-80.0%
3,058
-74.2%
0.00%
-80.0%
Q3 2022$1,019,000
+15.1%
11,833
+50.4%
0.01%
+25.0%
Q1 2022$885,000
+338.1%
7,866
+501.8%
0.00%
+300.0%
Q4 2021$202,000
-66.9%
1,307
-70.2%
0.00%
-50.0%
Q3 2021$610,000
-12.9%
4,381
-4.5%
0.00%
-50.0%
Q1 2021$700,000
+94.4%
4,589
+26.8%
0.00%
+33.3%
Q4 2020$360,000
-61.9%
3,619
-63.5%
0.00%
-76.9%
Q3 2020$945,000
-11.2%
9,915
+4.2%
0.01%
-23.5%
Q2 2020$1,064,000
+21.3%
9,517
+13.2%
0.02%
+240.0%
Q4 2019$877,000
-4.7%
8,409
+4.3%
0.01%
-44.4%
Q2 2019$920,000
-46.4%
8,062
-41.0%
0.01%
-50.0%
Q1 2019$1,718,000
-46.8%
13,666
-42.6%
0.02%
-52.6%
Q4 2018$3,230,000
+385.7%
23,806
+882.9%
0.04%
+375.0%
Q3 2018$665,000
+113.1%
2,422
+60.8%
0.01%
+100.0%
Q2 2018$312,000
-11.9%
1,506
-42.0%
0.00%
-42.9%
Q3 2017$354,000
-64.1%
2,597
-68.0%
0.01%
-63.2%
Q2 2017$986,000
+181.7%
8,119
+151.3%
0.02%
-50.0%
Q4 2015$350,000
+11.5%
3,231
-12.0%
0.04%
-51.3%
Q3 2015$314,000
-52.1%
3,670
-43.5%
0.08%
-63.4%
Q2 2015$656,0006,5000.21%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Knott David M Jr 115,000$7,6822.90%
VILLERE ST DENIS J & CO LLC 483,347$32,2872.52%
Monarch Partners Asset Management LLC 62,327$4,163,4441.23%
Chicago Capital, LLC 319,054$21,312,8201.18%
RICE HALL JAMES & ASSOCIATES, LLC 285,634$19,080,3511.09%
Stephens Investment Management Group LLC 454,416$30,713,9770.56%
Smith, Graham & Co., Investment Advisors, LP 65,372$4,366,8500.53%
WOODSTOCK CORP 55,014$3,674,9350.49%
Court Place Advisors, LLC 15,533$1,037,6050.38%
ISTHMUS PARTNERS, LLC 19,830$1,324,6440.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders